Rises in LDL and HDL cholesterol, triglycerides tied to lower diabetes riskAugust 4, 2016Lipid DisordersCAD & AtherosclerosisDiabetes
Two incretin-based drugs linked to increased bile duct disease but not pancreatitisAugust 1, 2016DiabetesLipid Disorders
Metabolic health declining among the obese, despite improvements in BP and lipidsJuly 13, 2016DiabetesLipid DisordersHypertensionCAD & Atherosclerosis
What difference would an empagliflozin CVD indication make?July 7, 2016CAD & AtherosclerosisDiabetesLipid Disorders
FDA panel narrowly endorses empagliflozin’s cardiovascular mortality benefitJune 29, 2016DiabetesCAD & AtherosclerosisLipid Disorders
The end of polypill – statins for everyoneJune 22, 2016Lipid DisordersCAD & AtherosclerosisHypertension
